PAUL-ANDREW CROMER: Open Payments
NPI 1346623980 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 8 payments from 6 companies in 2025. Trend: 2023 $295 · 2024 $249 · 2025 $278
Education: $147Food & beverage: $131
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $147 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Antares Pharma, Inc. | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $16 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
Products named: XYOSTED, PLUVICTO, ORGOVYX, GEMTESA, BOTOX, Trelstar.
Industry payments across OK — which companies pay providers there.
